Atlas Trials

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Clinical trial NCT03611621 · COMPLETED

Trial details

NCT number
NCT03611621
Sponsor
Hansa Biopharma AB
Status
COMPLETED
Study type
OBSERVATIONAL
Kidney Transplant Failure and Rejection
Start date
2018-06-27
Primary completion
2023-02-14
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.